Contrast-enhanced ultrasound (CEUS) for assessment of perfusion patterns of musculoskeletal tumors
Recruiting
- Conditions
- D48.9Neoplasm of uncertain or unknown behaviour, unspecified
- Registration Number
- DRKS00028080
- Lead Sponsor
- Zentrum für Orthopädie, Unfallchirurgie und Paraplegiologie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Adult patients with a musculoskeletal tumor who are being treated surgically at the Heidelberg University Hospital are included in the study.
Exclusion Criteria
Age under 18 years
• Inability to consent
• Known intolerance to SonoVue® or other ultrasound contrast media.
• Severe heart failure (NYHA III and IV), right-to-left shunt in the heart, uncontrollable high blood pressure.
• Severe pulmonary disease, particularly severe obstructive pulmonary disease, ARDS and severe pulmonary arterial hypertension.
• Myocardial infarction within the last 14 days.
• Disorders of the galactose metabolism (galactosemia).
• Pregnancy and breast feeding period.
• Lack of informed consent or refusal to participate.
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The perfusion between benign and malignant soft tissue tumors differs significantly.
- Secondary Outcome Measures
Name Time Method Different perfusion patterns can be determined in the area of ??the tumor mass and thus the biopsy planning can be improved.